As of 2025-07-03, the Relative Valuation of Beam Therapeutics Inc (BEAM) is (114.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.88 USD, the upside of Beam Therapeutics Inc based on Relative Valuation is -675.5%.
The range of the Relative Valuation is (96.22) - (153.54) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.4x - 39.9x | 26.9x |
| Forward P/E multiples | 25.0x - 47.6x | 32.5x |
| Fair Price | (96.22) - (153.54) | (114.40) |
| Upside | -584.0% - -872.3% | -675.5% |
| Date | P/E |
| 2025-07-02 | -4.77 |
| 2025-07-01 | -4.55 |
| 2025-06-30 | -4.42 |
| 2025-06-27 | -4.36 |
| 2025-06-26 | -4.45 |
| 2025-06-25 | -4.35 |
| 2025-06-24 | -4.45 |
| 2025-06-23 | -4.34 |
| 2025-06-20 | -4.35 |
| 2025-06-18 | -4.41 |
| 2025-06-17 | -4.33 |
| 2025-06-16 | -4.31 |
| 2025-06-13 | -4.43 |
| 2025-06-12 | -4.53 |
| 2025-06-11 | -4.64 |
| 2025-06-10 | -4.69 |
| 2025-06-09 | -4.72 |
| 2025-06-06 | -4.82 |
| 2025-06-05 | -4.41 |
| 2025-06-04 | -4.45 |
| 2025-06-03 | -4.38 |
| 2025-06-02 | -4.20 |
| 2025-05-30 | -4.11 |
| 2025-05-29 | -4.24 |
| 2025-05-28 | -4.38 |
| 2025-05-27 | -4.42 |
| 2025-05-23 | -4.37 |
| 2025-05-22 | -4.48 |
| 2025-05-21 | -4.47 |
| 2025-05-20 | -4.61 |
| 2025-05-19 | -4.58 |
| 2025-05-16 | -4.64 |
| 2025-05-15 | -4.48 |
| 2025-05-14 | -4.48 |
| 2025-05-13 | -4.69 |
| 2025-05-12 | -4.74 |
| 2025-05-09 | -4.52 |
| 2025-05-08 | -4.48 |
| 2025-05-07 | -4.21 |
| 2025-05-06 | -4.15 |
| 2025-05-05 | -5.15 |
| 2025-05-02 | -5.25 |
| 2025-05-01 | -5.15 |
| 2025-04-30 | -5.17 |
| 2025-04-29 | -5.12 |
| 2025-04-28 | -5.14 |
| 2025-04-25 | -5.07 |
| 2025-04-24 | -5.24 |
| 2025-04-23 | -5.16 |
| 2025-04-22 | -4.97 |